LOFEXIDINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lofexidine Hydrochloride, and what generic alternatives are available?
Lofexidine Hydrochloride is a drug marketed by Indoco and is included in one NDA.
The generic ingredient in LOFEXIDINE HYDROCHLORIDE is lofexidine hydrochloride. Four suppliers are listed for this compound. Additional details are available on the lofexidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lofexidine Hydrochloride
A generic version of LOFEXIDINE HYDROCHLORIDE was approved as lofexidine hydrochloride by INDOCO on August 20th, 2024.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOFEXIDINE HYDROCHLORIDE?
- What are the global sales for LOFEXIDINE HYDROCHLORIDE?
- What is Average Wholesale Price for LOFEXIDINE HYDROCHLORIDE?
Summary for LOFEXIDINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Clinical Trials: | 42 |
| Patent Applications: | 183 |
| DailyMed Link: | LOFEXIDINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for LOFEXIDINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| USWM, LLC (dba US WorldMeds) | Phase 2 |
| Clinilabs, Inc. | Phase 1/Phase 2 |
| Yale University | Phase 1/Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for LOFEXIDINE HYDROCHLORIDE
US Patents and Regulatory Information for LOFEXIDINE HYDROCHLORIDE
LOFEXIDINE HYDROCHLORIDE is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting LOFEXIDINE HYDROCHLORIDE
COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indoco | LOFEXIDINE HYDROCHLORIDE | lofexidine hydrochloride | TABLET;ORAL | 218613-001 | Aug 20, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
